Allopurinol Accord 100 mg tabletes Latvia - Latvia - Zāļu valsts aģentūra

allopurinol accord 100 mg tabletes

accord healthcare b.v., netherlands - allopurinols - tablete - 100 mg

Allopurinol Accord 300 mg tabletes Latvia - Latvia - Zāļu valsts aģentūra

allopurinol accord 300 mg tabletes

accord healthcare b.v., netherlands - allopurinols - tablete - 300 mg

Milurit 150 mg tabletes Latvia - Latvia - Zāļu valsts aģentūra

milurit 150 mg tabletes

egis pharmaceuticals plc, hungary - allopurinols - tablete - 150 mg

Milurit 200 mg tabletes Latvia - Latvia - Zāļu valsts aģentūra

milurit 200 mg tabletes

egis pharmaceuticals plc, hungary - allopurinols - tablete - 200 mg

Xeljanz Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

xeljanz

pfizer europe ma eeig - tofacitinibs - artrīts, reimatoīds - imūnsupresanti - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 un 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.

Zenapax Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

zenapax

roche registration ltd. - daclizumab - graft rejection; kidney transplantation - imūnsupresanti - zenapax ir indicēts orgānu akūtu atteikuma de novo allogenic nieru transplantācijas profilaksei un ir jālieto kopā ar imunitāti nomācošu režīms, ieskaitot cyclosporine un kortikosteroīdi pacientiem, kuriem nav imunizēti augsti.

Mavenclad Kesatuan Eropah - Latvia - EMA (European Medicines Agency)

mavenclad

merck europe b.v. - kladribīns - multiplā skleroze - imūnsupresanti - pieaugušiem pacientiem ar augsti aktīvo recidivējošo multiplo sklerozi (ms), kā definēts klīniskās vai attēlveidošanas īpašībās.

Arduan 4 mg pulveris un šķīdinātājs injekciju šķīduma pagatavošanai Latvia - Latvia - Zāļu valsts aģentūra

arduan 4 mg pulveris un šķīdinātājs injekciju šķīduma pagatavošanai

gedeon richter plc., hungary - pipekuronija bromīds - pulveris un šķīdinātājs injekciju šķīduma pagatavošanai - 4 mg

Lidaprim Forte 800 mg/160 mg apvalkotās tabletes Latvia - Latvia - Zāļu valsts aģentūra

lidaprim forte 800 mg/160 mg apvalkotās tabletes

rokitan gmbh, austria - trimethoprimum, sulfametrolum - apvalkotā tablete - 800 mg/160 mg

Methotrexate "Ebewe" 5 mg tabletes Latvia - Latvia - Zāļu valsts aģentūra

methotrexate "ebewe" 5 mg tabletes

sandoz d.d., slovenia - metotreksāts - tablete - 5 mg